AstraZeneca received approval for Enhertu Expansion in India as the company received regulatory approval for the expanded use of its breast cancer drug Enhertu. The approval from the Central Drugs Standard Control Organisation (CDSCO)...
India may be preparing to offer fresh support to the pharmaceutical industry as it considers extending customs duty exemptions on key petrochemical imports. The proposed duty relief for pharma raw materials comes at a time when drug manufacturers...
India is preparing a major policy initiative aimed at boosting domestic pharmaceutical innovation, with the government working on a new scheme focused on the bulk drug research ecosystem. The proposed initiative is expected to strengthen...
.jpeg)
ICRA report shows India pharma improving ESG metrics with higher renewable energy use, but facing challenges in energy intensity, hazardous waste, and governance gaps amid global compliance pressure.
AstraZeneca’s experimental breast cancer pill, camizestrant has received a regulatory boost in Europe, despite its trial design facing US regulatory pushback.
Reinforcing its position as a leading destination for advanced neurosciences care, Aster CMI Hospital has introduced two state-of-the-art robotic platforms for neurosurgery — Mazor X for spine surgery and ROSA for cranial and brain procedures.
The Indian Patent Office has refused to grant US pharmaceutical firm AbbVie a Hepatitis C patent for its combination therapy glecaprevir/pibrentasvir, marketed globally as Mavyret.
Calpol has long been a trusted name in Indian households, especially among parents looking for quick fever and pain relief for children. Now, Calpol has received one of the strongest forms of legal recognition in India after the Delhi High Court...
Reporting its fourth quarter results for FY 26, Zydus Wellness, reported a consolidated growth of 62.1% in Net Sales which stood at Rs. 14,761 million as compared to Rs. 9,106 million in the corresponding period of the previous year.
Cancer drug research continues to transform the global pharmaceutical industry as companies race to develop affordable and advanced oncology treatments. New FDA clearances reflect rapid growth in cancer drug research, especially in the breast...
.jpg)
, CDSCO.jpg)